-Zhong-Yuan Xiao Researcher Activity Profile

Research Author Detailed Information 

Zhong-Yuan Xiao Publication Rate By Year

Zhong-Yuan Xiao has published 1 paper(s) in 1993, 1 paper(s) in 2005, 4 paper(s) in 2006, 9 paper(s) in 2007, for a total of 15 research publications in total.

Zhong-Yuan Zy Xiao Author Information

LAST NAME: xiao

FIRST NAME: Zhong-Yuan

INITIALS: zy

AFFILIATION:

Papers

Zhong-Yuan Xiao's Publication Record

1. [The effect of fermentation conditions on glycosylation of recombinant human interferon omega in yeast Pichia pastoris] Year Published: 2005
College of Bioengineering, Key Laboratory of Biomechanics & Tissue Engineering under the State Ministry of Education, Chongqing University, Chongqing 400044, China.
2. [Study on the associated risk factors of rheumatic pain: a ILAR-China, WHO COPCORD Shantou study] Year Published: 2006
Department of Rheumatology, First Afilliated Hospital of Shantou University Medical College, Shantou 515041, China.
3. [Study on rare earth doped long luminescence glass] Year Published: 2006
Changchun University of Science and Technology, Changchun 130022, China.
4. [Surveillance of antimicrobial susceptibility of Streptococcus pneumoniae and Hemophilus influenzae isolated from children in Guangzhou area between 2003 and 2004] Year Published: 2006
Department of Respiratory Diseases, Guangzhou Children's Hospital, Guangzhou 510120, China.
5. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof] Year Published: 2006
Department of Anesthesiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
6. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production. Year Published: 2007
Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Haidian District, Beijing 100850, PR China.
7. Polyisoprenylated Benzoylphloroglucinol Derivatives from Hypericum sampsonii. Year Published: 2007
muqing2000@yahoo.com.
8. Polyisoprenylated benzoylphloroglucinol derivatives from Hypericum sampsonii. Year Published: 2007
School of Pharmacy, Fudan University, Shanghai 200032, People's Republic of China.
9. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation. Year Published: 2007
Beijing Institute of Pharmacology and Toxicology, Beijing, China.
10. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production. Year Published: 2007
Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Haidian District, Beijing 100850, PR China.
11. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production. Year Published: 2007
Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Haidian District, Beijing 100850, PR China.
12. Polyisoprenylated benzoylphloroglucinol derivatives from Hypericum sampsonii. Year Published: 2007
School of Pharmacy, Fudan University, Shanghai 200032, People's Republic of China.
13. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation. Year Published: 2007
Beijing Institute of Pharmacology and Toxicology, Beijing, China.
14. [Chemical constituents of Drynaria propinqua (Wall) J. Sm] Year Published: 1993
School of Pharmacy, West China University of Medical Sciences, Chengdu.
15. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation. Year Published: 2007
Beijing Institute of Pharmacology and Toxicology, Beijing, China.